High-Value T Cell Epitope Selection for Mutanome-Directed Cancer Immunotherapy Using an Innovative Cancer Neo-Epitope Classification System
The ISPRI Toolkit Rapidly Screens Biologic Product Candidates for Immunogenic Potential Driven by T cell Epitope Content and Foreignness
